Don't leave, TurboMice™ is coming to you!
Connecting to server... 0%
  • 4-Week Delivery: World’s fastest custom mouse model development.
  • TurboMice™ Tech: Proprietary high-efficiency gene-editing platform.
  • Full Capabilities: Expert conditional knockouts, knock-ins, and humanized models.
  • Validated Quality: Guaranteed high precision and model viability.
Partners' Projects

Bach1 KO Mouse Model

Category
Strain Name

Bach1 KO Mouse Model (M10044)

Editing Type

Knockout

Gene Name

Bach1 (BTB and CNC homology 1, basic leucine zipper transcription factor 1; human ortholog BACH1)

Gene Synonyms

6230421P05Rik

Strain Background

C57BL/6N

NCBI No.

Gene ID 12013

  • Oxidative stress and antioxidant defense — Constitutive loss of Bach1 de-represses HO-1 and NQO1, giving a stable baseline of elevated antioxidant gene expression against which Nrf2-axis interventions can be tested.
  • Ferroptosis — Bach1 sits at the junction of two opposing arms: it represses FTL/FTH1 and SLC7A11, while its loss de-represses HO-1 and drives heme-derived iron release. Sensitivity therefore moves with the model, which makes this strain a tool for resolving the direction rather than assuming it.
  • Ischemia-reperfusion and organ injury — Published protection in myocardial I/R, pressure overload, hepatic injury, hyperoxic lung injury, spinal cord injury and atherosclerosis (in the ApoE double-null setting) provides ready benchmarks to reproduce or extend.
  • Cancer metastasis — Nrf2 activation stabilises Bach1 and drives lung cancer metastasis; the strain allows that axis to be interrupted at the Bach1 node rather than upstream.
  • Inflammation and macrophage biology — HO-1-expressing M2 macrophages are enriched in Bach1-null settings, supporting macrophage-polarisation readouts.

This strain carries a constitutive null allele of Bach1, which encodes BTB and CNC homology 1, a bZIP transcriptional repressor of antioxidant response elements. Bach1 heterodimerises with small Maf proteins and occupies Maf-recognition elements in the promoters of HMOX1, NQO1, FTH1, FTL, SLC40A1, SLC48A1 and SLC7A11, competing with Nrf2 for the same sites. Because it lacks a transactivation domain, occupancy means repression. Heme binding to the BTB domain releases Bach1 from DNA and triggers its nuclear export and degradation, so the protein is a direct heme sensor as well as a redox-responsive repressor. Removing Bach1 lifts that repression constitutively, raising baseline HO-1 and ferritin expression and shifting the cell’s handling of heme, iron and lipid peroxides. This makes the line informative both for loss-of-repression experiments and for separating genetic from pharmacological Bach1 inhibition.

  1. The HO-1 link is unequivocal, not inferred — Human and mouse HMOX1 are both established Bach1 targets; the de-repression phenotype is the most reproducible readout this gene offers.
  2. Multiple in vivo phenotypes already exist — Hepatic injury, myocardial ischemia-reperfusion, pressure overload, hyperoxic lung injury, spinal cord injury and ApoE-dependent atherosclerosis all have published Bach1-null data. Customers get a benchmark rather than a blank slate.
  3. Sits at the centre of the ferroptosis decision — Repressing FTL/FTH1 and SLC7A11 while de-repressing HO-1 puts Bach1 on both sides of the iron-lipid peroxide balance, which is precisely the variable ferroptosis studies need to control.
  4. Genetic versus pharmacological comparison in one strain — Because heme and Hoil-1-mediated degradation switch Bach1 off post-translationally, a null line lets the same question be asked by deletion and by chemical inactivation, with the genotype as the internal control.
  5. A metastasis axis with top-tier backing — Nrf2-driven stabilisation of Bach1 promotes lung cancer metastasis, so the strain supports metastasis work at the node the field is now targeting.

FAQ

Game-changing benefits?

While competitors highlight germline efficiency gains, shorter timelines and enhanced 3Rs animal welfare benefits for their technologies, these are merely incremental improvements over traditional approaches. In sharp contrast, our proprietary technology delivers fully pure, homogeneous lineages—every single cell of the mice is derived exclusively from totipotent ES cells, with guaranteed 100% germline transmission efficiency. To experience these unparalleled benefits firsthand, enquire about your custom mouse model project with us or order embryos for in-house validation at your facility.

•Free initial design proposal with zero obligations.​
•Request a free quote!

All model generation projects of Mingceler operate under a fee-for-service framework.
IP Ownership: All intellectual property rights related to custom mouse models, including derived organs, tissues, cells, and biological materials, are the sole and exclusive property of the Client.
Third-Party Transfer Permission: The Client may independently decide to retain, utilize, or commercialize their custom models project materials (e.g., targeting vectors, ES cells, mouse lines) without the need for prior consent from Mingceler.
Licensing Exemption: The Client has full autonomy over all uses of the custom models or their derivatives, including but not limited to commercialization, distribution to third parties, and publication involving model data. No written license from Mingceler is required for such uses.

This website uses cookies

We use cookies to personalize content, provide social media features, and analyze our traffic. We also share information about your use of our site with our analytics partners. You can change your preferences at any time. For more information, please see our Privacy Policy Cookie Policy